-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TdypAxvlagxUsxhWd/v/AMpiDEjN4qsgR9D86lAZP0i6DhDUFpAOPKixfiDTg3Xp D8HBgpxdAHQzsGUiAmuphg== 0001145549-08-000279.txt : 20080212 0001145549-08-000279.hdr.sgml : 20080212 20080212061420 ACCESSION NUMBER: 0001145549-08-000279 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20080212 DATE AS OF CHANGE: 20080212 GROUP MEMBERS: HONY CAPITAL II GP, LTD. GROUP MEMBERS: HONY CAPITAL II, L.P. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Simcere Pharmaceutical Group CENTRAL INDEX KEY: 0001384360 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-83690 FILM NUMBER: 08595654 BUSINESS ADDRESS: STREET 1: NO. 699-18 XUAN WU AVENUE STREET 2: XUAN WU DISTRICT CITY: NANJING, JIANGSU PROVINCE STATE: F4 ZIP: 210042 BUSINESS PHONE: (86)-25-8556-6666 MAIL ADDRESS: STREET 1: NO. 699-18 XUAN WU AVENUE STREET 2: XUAN WU DISTRICT CITY: NANJING, JIANGSU PROVINCE STATE: F4 ZIP: 210042 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Assure Ahead Investments LTD CENTRAL INDEX KEY: 0001425931 IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 6F FLOOR, SOUTH TOWER C, RAYCOM INFOTECH STREET 2: PARK, NO.2 KEXUEYUAN NANLU CITY: HAIDIAN DISTRICT, BEIJING STATE: F4 ZIP: 100080 BUSINESS PHONE: 86 (10) 6250 9988 MAIL ADDRESS: STREET 1: 6F FLOOR, SOUTH TOWER C, RAYCOM INFOTECH STREET 2: PARK, NO.2 KEXUEYUAN NANLU CITY: HAIDIAN DISTRICT, BEIJING STATE: F4 ZIP: 100080 SC 13G 1 h01877sc13g.htm SIMCERE PHARMACEUTICAL GROUP SIMCERE PHARMACEUTICAL GROUP
Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO
FILED PURSUANT TO 13d-2
Simcere Pharmaceutical Group
 
(Name of Issuer)
Ordinary Shares, par value US$0.01 per share
 
(Title of Class of Securities)
82859P 10 41
 
(CUSIP Number)
December 31, 2007
 
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
  o    Rule 13d-1(b)
 
  o    Rule 13d-1(c)
 
  þ    Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
[Continued on following pages]
 
1   This CUSIP number applies to the Issuer’s American Depositary Shares, each representing two Ordinary Shares.
 
 


TABLE OF CONTENTS

SIGNATURE
EX-99.1 JOINT FILING AGREEMENT


Table of Contents

                     
CUSIP No.
 
82859P 10 4 
  Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS
Assure Ahead Investments Limited
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  British Virgin Islands
       
  5   SOLE VOTING POWER
     
NUMBER OF   26,437,600 Ordinary Shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   26,437,600 Ordinary Shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  26,437,600 Ordinary Shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  20.8%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO


Table of Contents

                     
CUSIP No.
 
82859P 10 4 
  Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS
Hony Capital II, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Cayman Islands
       
  5   SOLE VOTING POWER
     
NUMBER OF   26,437,600 Ordinary Shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   26,437,600 Ordinary Shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  26,437,600 Ordinary Shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  20.8%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN


Table of Contents

                     
CUSIP No.
 
82859P 10 4 
  Page  
  of   

 

           
1   NAMES OF REPORTING PERSONS
Hony Capital II GP Ltd.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Cayman Islands
       
  5   SOLE VOTING POWER
     
NUMBER OF   26,437,600 Ordinary Shares
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   26,437,600 Ordinary Shares
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  26,437,600 Ordinary Shares
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  20.8%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  CO


Table of Contents

         
CUSIP NO. 82859P 10 4   Schedule 13G   Page 5 of 8 Pages
ITEM 1(a).    NAME OF ISSUER:
 
    Simcere Pharmaceutical Group (the “Issuer”)
 
ITEM 1(b).    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
 
    No. 699-18 Xuan Wu Avenue
Xuan Wu District, Nanjing
Jiangsu Province 210042
People’s Republic of China
 
ITEM 2(a).    NAME OF PERSON FILING:
 
    This Schedule 13G is filed by and on behalf of (a) Assure Ahead Investments Limited, (b) Hony Capital II, L.P. and (c) Hony Capital II GP Ltd. Hony Capital II, L.P. holds a majority equity interest in Assure Ahead Investments Limited and has the sole right to appoint and remove all directors of Assure Ahead Investments Limited. Pursuant to Rule 13d-3 under the Act, Hony Capital II, L.P. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuer owned by Assure Ahead Investments Limited. Hony Capital II GP Ltd. is the general partner of Hony Capital II, L.P. Pursuant to Rule 13d-3 under the Act, Hony Capital II GP Ltd. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuers beneficially owned by Hony Capital II, L.P. Assure Ahead Investments Limited, Hony Capital II, L.P. and Hony Capital II GP Ltd. are making this single, joint filing pursuant to Rule 13d-1(k) of the Act because each of them is reporting as to the beneficial ownership of the same securities.
 
ITEM 2(b).    ADDRESS OF PRINCIPAL BUSINESS OFFICE, OR, IF NONE, RESIDENCE:
 
    The address of principal business office of each of Assure Ahead Investments Limited, Hony Capital II, L.P. and Hony Capital II GP Ltd. is 6th Floor, South Tower C, Raycom InfoTech Park, No.2 Kexueyuan Nanlu, Haidian District, Beijing 100080, the People’s Republic of China
 
ITEM 2(c)    CITIZENSHIP:
 
    Assure Ahead Investments Limited is a British Virgin Islands company.
Hony Capital II, L.P. and Hony Capital II GP Ltd. are chartered in Cayman Islands.

 


Table of Contents

         
CUSIP NO. 82859P 10 4   Schedule 13G   Page 6 of 8 Pages
ITEM 2(d).    TITLE OF CLASS OF SECURITIES:
 
    Ordinary Shares
 
ITEM 2(e).    CUSIP NUMBER:
 
    82859P 10 4
 
ITEM 3.    STATEMENT FILED PURSUANT TO RULE 13d-1(b) or 13d-2(b) or (c):
 
    Not applicable.
 
ITEM 4.    OWNERSHIP.
 
    The following information with respect to the ownership of the Ordinary Shares of the Issuer by the persons filing this statement is provided as of December 31, 2007. The percentage amounts are based on 127,209,200 Ordinary Shares outstanding as of December 31, 2007, as derived from the Issuer’s corporate records.
                                                 
Reporting Person   Amount
beneficially
owned:
  Percent
of class:
  Sole power
to vote or
direct
the vote:
  Shared
power to
vote or to
direct
the vote:
  Sole power to
dispose or to
direct the
disposition of:
  Shared power
to dispose or to
direct the
disposition of:
Assure Ahead Investments Limited
    26,437,600       20.8 %     26,437,600             26,437,600        
 
                                               
Hony Capital II, L.P.
    26,437,600       20.8 %     26,437,600             26,437,600        
 
                                               
Hony Capital II GP Ltd.
    26,437,600       20.8 %     26,437,600             26,437,600        
    Assure Ahead Investments Limited is the record holder of 26,437,600 Ordinary Shares of the Issuer. Hony Capital II, L.P. holds a majority equity interest in Assure Ahead Investments Limited and has the sole right to appoint and remove all directors of Assure Ahead Investments Limited. Pursuant to Rule 13d-3 under the Act, Hony Capital II, L.P. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuer owned by Assure Ahead Investments Limited. Hony Capital II GP Ltd. is the general partner of Hony Capital II, L.P. Pursuant to Rule 13d-3 under the Act, Hony Capital II GP Ltd. may be deemed to be the beneficial owner of the Ordinary Shares of the Issuers beneficially owned by Hony Capital II, L.P.
 
ITEM 5.    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
 
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: o
 
ITEM 6.    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
 
    Not applicable

 


Table of Contents

         
CUSIP NO. 82859P 10 4
  Schedule 13G   Page 7 of 8 Pages
ITEM 7.    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
 
    Hony Capital II, L.P. is the controlling shareholder of Assure Ahead Investments Limited. Hony Capital II GP Ltd. holds a general partnership interest in Hony Capital II, L.P.
 
ITEM 8.    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
 
    Not applicable
 
ITEM 9.    NOTICE OF DISSOLUTION OF GROUP.
 
    Not applicable
 
ITEM 10.    CERTIFICATION.
 
    Not applicable

 


Table of Contents

         
CUSIP NO. 82859P 10 4   Schedule 13G   Page 8 of 8 Pages
SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 12, 2008
         
  Assure Ahead Investments Limited
 
 
  By:   /s/ Yonggang Cao    
    Yonggang Cao   
    Director   
 
  Hony Capital II, L.P.
Acting by its general partner
Hony Capital II GP Ltd.
 
 
  By:   /s/ John Huan Zhao    
    John Huan Zhao   
    a duly authorized representative   
 
  Hony Capital II GP LTD.
 
 
  By:   /s/ John Huan Zhao    
    John Huan Zhao   
    Director   
 

EX-99.1 2 h01877exv99w1.htm EX-99.1 JOINT FILING AGREEMENT EX-99.1 JOINT FILING AGREEMENT
 

EXHIBIT 99.1
Joint Filing Agreement
     In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Ordinary Shares, par value US$0.01 per share, of Simcere Pharmaceutical Group, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
[Remainder of this page has been left intentionally blank.]

 


 

Signature Page
     IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 12, 2008.
         
  Assure Ahead Investments Limited
 
 
  By:   /s/ Yonggang Cao    
    Yonggang Cao   
    Director   
 
  Hony Capital II, L.P.
Acting by its general partner
Hony Capital II GP Ltd.
 
 
  By:   /s/ John Huan Zhao    
    John Huan Zhao   
    a duly authorized representative   
 
  Hony Capital II GP LTD.
 
 
  By:   /s/ John Huan Zhao    
    John Huan Zhao   
    Director   
 

 

-----END PRIVACY-ENHANCED MESSAGE-----